Evaluation of the effect of agomelatine and escitalopram on emotions and motivation in healthy male and female volunteers

Trial Profile

Evaluation of the effect of agomelatine and escitalopram on emotions and motivation in healthy male and female volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Agomelatine (Primary) ; Escitalopram
  • Indications Anxiety disorders; Major depressive disorder
  • Focus Pharmacodynamics
  • Sponsors IRIS
  • Most Recent Events

    • 31 May 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 08 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top